Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Parkinson Disease in United States

252 results

Sort By:

Pathways Mediating Impaired Postural Control in Parkinson's Disease

Study ID: NCT06464029
Start Date: 2024-06-01
End Date: 2027-06-10
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment
Sponsor

University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

Study ID: NCT07219927
Start Date: 2025-03-31
End Date: 2027-08-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Observational study

Sponsor

Supernus Pharmaceuticals, Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Study ID: NCT06345729
Start Date: 2024-05-24
End Date: 2031-02-18
Study Type

Interventional

Study Phase

Phase3

No. of Participants

600

Intervention / Treatment

Boilersib

Placebo

Pembrolizumab

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations

Study ID: NCT07424365
Start Date: 2025-05-19
End Date: 2028-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

transcutaneous auricular vagus nerve stimulation

sham stimulation

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

Exercise for Cognitive Excellence in Parkinson's Disease

Study ID: NCT05720468
Start Date: 2023-07-20
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

32

Intervention / Treatment

Exercise

No Exercise

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

Remote Therapeutic Monitoring Exercise Tracking

Study ID: NCT06306768
Start Date: 2024-04-01
End Date: 2028-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Activity Monitoring

Sponsor

Shirley Ryan AbilityLab

Source: clinicaltrials.gov

Share:
Add to list

Neurologic Stem Cell Treatment Study

Study ID: NCT02795052
Start Date: 2016-06
End Date: 2027-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

Intravenous and Intranasal BMSC

Sponsor

MD Stem Cells

Source: clinicaltrials.gov

Share:
Add to list

Aim 3 Particle Swarm Optimization PIGD

Study ID: NCT05934747
Start Date: 2024-03-19
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

DBS

Sponsor

University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Tenapanor in Synucleinopathy-Related Constipation

Study ID: NCT06460038
Start Date: 2025-01-01
End Date: 2027-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Tenapanor

Placebo

Sponsor

Cedar Valley Digestive Health Center

Source: clinicaltrials.gov

Share:
Add to list

Parkinson's Foundation Surveys

Study ID: NCT05066763
Start Date: 2021-04-02
End Date: 2030-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000000

Intervention / Treatment

Non-interventional

Sponsor

Parkinson's Foundation

Source: clinicaltrials.gov

Share:
Add to list